<i>In silico</i> and <i>in vitro</i> evaluation of imatinib as an inhibitor for SARS-CoV-2-Reference-Cited by-同舟云学术

In silico and in vitro evaluation of imatinib as an inhibitor for SARS-CoV-2

Published:2022-02-26 Issue:7 Volume:41 Page:3052-3061
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Mulgaonkar Nirmitee¹^ORCID,Wang Haoqi¹^ORCID,Mallawarachchi Samavath¹^ORCID,Růžek Daniel²^ORCID,Martina Byron³^ORCID,Fernando Sandun¹^ORCID

Affiliation:

1. Biological and Agricultural Engineering Department, Texas A&M University, College Station, TX, USA

2. Veterinary Research Institute, Brno, and Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic

3. Artemis One Health Research Institute, Delft, The Netherlands

Funder

Ministry of Health of the Czech Republic

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2022.2045221

Reference44 articles.

1. (CDC), C. f. D. C. a. P. (2021). Treatments Your Healthcare Provider Might Recommend if You Are Sick. https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html

2. (NIH), N. I. o. H. (2021). What;s New in the Guidelines. https://www.covid19treatmentguidelines.nih.gov/about-the-guidelines/whats-new/

3. (WHO), W. H. O. (2020). World Health Organization “Solidarity” clinical trial for COVID-19 treatments. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments

4. Allaire, J. (2012). RStudio: Integrated development environment for R. Boston, MA, 537, 538.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specifically targeting antimicrobial peptides for inhibition of Candidatus Liberibacter asiaticus;Journal of Applied Microbiology;2024-03-20

2. Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction;Medicinal Chemistry Research;2024-03-05

3. Design, synthesis, and biological and computational evaluation of novel oxindole derivatives as inhibitors of Aurora A Kinase and SARS-CoV-2 Spike/Host ACE2 Interaction;2024-01-09

4. Identification of Fungicide Combinations for Overcoming Plasmopara viticola and Botrytis cinerea Fungicide Resistance;Microorganisms;2023-12-12

5. Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant;Pharmaceutics;2023-07-05